BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxycycline
,
rs6983267
,
PPARA
,
cell-cell adhesion
,
Leukemia
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
poor-prognostic
Summary
General Info
Curated Studies
Most Correlated Studies
Leukemia cell lines with low or high expression of the poor prognostic marker EVI1
Clear cell renal cell carcinoma A498 cells with siRNA knockdown of SET domain containing 2 (SETD2)
Hepatocellular carcinoma vs. corresponding noncancerous liver or normal liver
WBCs from T-cell acute lymphoblastic leukemia patients with high or low CRLF2 expression
Squamous cell carcinomas from p53 single or p53 and Rb double conditional epidermal knockouts
Explore Curated Studies Results
Literature
Most Relevant Literature
GRIK1 promotes glioblastoma malignancy and is a novel prognostic factor of poor prognosis.
Synovial tissue features associated with poor prognosis in inflammatory arthritis.
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease pat…
Analysis of Predictive Factors for the Poor Prognosis of Peripheral Facial Paralysis.
Peripheral biomarkers as a predictor of poor prognosis in severe cases of COVID-19.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatments for Brain Metastases With Poor Prognostic Factors
Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors
Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cerv…
Optimal Timing of Coronary Artery Bypass Grafting in Hemodynamically Stable Patient After Myocardial…
Are You in a Poor Country; HIPEC is Still in Reach
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ